Alliance Boots announced its annual results for the year ended March 31, 2013, with revenue of £22.4 billion, down 2.6% but up 0.6% in constant currency. Revenue for its health and beauty division was £865 million, up 6.8% (7% in constant currency), with the U.K contributing £813 million of that, up 8.8%.
Strategically, the company also discussed its new partnership with Walgreens. Stefano Pessina, Alliance Boots’ executive chairman, commented, “This has been a transformational year for Alliance Boots due to our exciting new strategic partnership with Walgreens, which we are further strengthening by our recent joint agreement to partner with AmerisourceBergen.
“Against the backdrop of this major corporate activity, and the challenging conditions across our markets, we have again delivered a double-digit growth in underlying profit after tax. Our people are at the heart of everything we do and it is through clear leadership combined with great teamwork that we have been able to deliver such consistently good results.
“We continue to be confident about our prospects and ability to pursue profitable growth, organically, from our synergy programs and through international expansion.
“In a world where globalization is increasing at a pace, our transformational partnerships put us together in a unique position to become the clear world leader in both pharmacy and pharmaceutical wholesale. I truly believe that we have the brands, intellectual capital and, most importantly, the management expertise to create value for our stakeholders across the world for many years ahead.”